The “Protein Crystallization & Crystallography Market by Technology (Ion-Exchange Chromatography, HPLC, Gel-Electrophoresis, NMR, X-Ray Crystallography), Products (Reagents & Instruments) & End-Users (Pharmaceutical & Biotechnology Companies) - Forecast to 2018” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market, estimates and forecasts of revenue, and share analysis.
Browse more than 71 market data tables with 20 figures spread through 251 pages and in-depth TOC on "Protein Crystallization & Crystallography Market".
Early buyers will receive 10% customization on this report.
The global market was valued at $775 million in 2013 and is expected to reach $1,253 million by 2018. The increasing use of crystallization for membrane protein structure elucidation, increasing R&D by big pharmaceutical and biotechnology firms, technological advancements, and increasing government funding are the major factors driving the market. New and innovative product launches by key industry players also boost the growth momentum of this market. Nevertheless, lack of qualified and experienced researchers and reduction in healthcare budgets are critical restraints for market growth.
The protein crystallography market is segmented on the basis of technologies, applications, products (instruments and reagents), and end users. Based on technology, the global market is further segmented into protein purification, protein crystallization, protein crystal mounting, and protein crystallography. Protein crystallization is the most crucial and the largest segment, and it accounted for 47% of the market in 2013. On the basis of products, the protein crystallization & crystallography market has segments such as reagents/consumables and instruments. Reagents/consumables accounted for 85% of the protein crystallization & crystallography product market. It is expected to grow at a high CAGR of 11% over the forecast period.
Download Free Sample copy of report: http://www.marketsandmarkets.com/requestsample.asp?id=147057058
The future growth prospects for the protein crystallization market are optimistic which is estimated to grow at a CAGR of 10.1% to reach a worldwide market of $1,253 million by 2018. The increasing use of crystallization for membrane protein structure elucidation, increasing R&D by big pharmaceutical and biotechnology firms, technological advancements, and increasing government funding are all factors that are expected to fuel the growth of the market in the near future. However, insufficiency of qualified and experienced researchers, lack of generalized crystallization methods associated with the types of proteins, and highly time-consuming and expensive protein crystallization and crystallography processes are expected to hinder the growth of this market during the forecasted period. The key unmet market needs provide huge opportunities for both, the key players and new entrants in this industry.
Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=147057058
North America is the largest market, closely followed by Europe. Both markets will register high single-digit growth rates for the next five years. The Asian market is poised to grow at a double-digit rate owing to the increasing investment opportunities for companies in these immature markets and the increased focus of pharmaceutical and biotechnology companies towards the Asian region as an R&D outsourcing destination.
The market is dominated by Rigaku Corporation (Japan), followed by Hampton Research (U.S.), Jena Bioscience GmbH (Germany), Molecular Dimensions Ltd. (U.K.), Formulatrix, Inc. (U.S.), Bruker Corporation (U.S.), and MiTeGen LLC (U.S.).
Browse related reports:
Proteomics Market (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & Services - Trends & Global Forecasts to 2017
Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets